Last 12 months
Inside the activity.
0 purchase rows · 15 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2021 Filed May 24, 2021 21:08 UTC |
Harsanyi ZsoltDirector
|
GrantCommon Stock | 5,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000093 · wf-form4_162189049034879.xml · nonDerivative · entry 1 Harsanyi Zsolt · CIK 0001380184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,606 F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company. Read SEC document |
| May 20, 2021 Filed May 24, 2021 21:05 UTC |
Richard RonaldDirector
|
GrantCommon Stock | 5,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000091 · wf-form4_162189033525294.xml · nonDerivative · entry 1 Richard Ronald · CIK 0001380177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,303 F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. F2 · shares: These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:18 UTC |
SULLIVAN LOUIS WDirector
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 10,305 | $0.00 Strike: $18.64 | $0.00 |
DisclosureSEC source: 0001367644-21-000075 · wf-form4_162076428587593.xml · derivative · entry 3 SULLIVAN LOUIS W · CIK 0001193522 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,305 shares Expires 2021-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Consists of an option granted under the company's stock incentive plan as amended and restated. F3 · derivative.exercise_date: The option vested in three equal installments in May 2015, May 2016 and May 2017. Each option represents the right of the reporting person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:18 UTC |
SULLIVAN LOUIS WDirector
|
Tax withholdingCommon Stock | 3,118 | $61.62 | $192,131.16 |
DisclosureSEC source: 0001367644-21-000075 · wf-form4_162076428587593.xml · nonDerivative · entry 2 SULLIVAN LOUIS W · CIK 0001193522 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,945 F1 · security: Consists of shares owned by the reporting person and delivered to the issuer to satisfy the reporting persons exercise price for the reported stock option exercise. Read SEC document |
| May 10, 2021 Filed May 11, 2021 20:18 UTC |
SULLIVAN LOUIS WDirector
|
Exercise / conversionCommon Stock | 10,305 | $18.64 | $192,085.20 |
DisclosureSEC source: 0001367644-21-000075 · wf-form4_162076428587593.xml · nonDerivative · entry 1 SULLIVAN LOUIS W · CIK 0001193522 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2021 Filed May 11, 2021 20:27 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 1,054 | $61.62 | $64,947.48 |
DisclosureSEC source: 0001367644-21-000079 · wf-form4_162076485462525.xml · nonDerivative · entry 1 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,919 F1 · security: Represents shares of common stock withheld to pay taxes upon vest of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| May 08, 2021 Filed May 11, 2021 20:25 UTC |
Kramer RobertDirector · President and CEO
|
Tax withholdingCommon Stock | 94 | $61.62 | $5,792.28 |
DisclosureSEC source: 0001367644-21-000077 · wf-form4_162076469265250.xml · nonDerivative · entry 1 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,053 F1 · security: Represents shares of common stock withheld to pay taxes upon vest of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| May 07, 2021 Filed May 11, 2021 20:30 UTC |
Smith Karen L.EVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 305 | $60.85 | $18,559.25 |
DisclosureSEC source: 0001367644-21-000081 · wf-form4_162076498795882.xml · nonDerivative · entry 1 Smith Karen L. · CIK 0001639637 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,888 F1 · security: Represents shares of common stock withheld to pay taxes upon vest of restricted stock units granted under the company's stock incentive plan, as amended and restated. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 22:54 UTC |
Kirk SeanEVP, Manufacturing & Tech Ops
|
Tax withholdingCommon Stock | 159 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000055 · wf-form4_161731759604526.xml · nonDerivative · entry 1 Kirk Sean · CIK 0001778426 · EVP, Manufacturing & Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,776 F1 · security: Represents shares of common stock withheld to pay taxes upon vest of restricted stock units granted under the company's stock incentive plan, as amended and restated Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 18:30 UTC |
Bailey SueDirector
|
SaleCommon Stock | 8,168 | $92.37 | $754,478.16 |
DisclosureSEC source: 0001367644-21-000051 · wf-form4_161524624160313.xml · nonDerivative · entry 1 Bailey Sue · CIK 0001403769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,427 F1 · security: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. F2 · shares: These shares are held of record by a living trust, for which the Reporting Person serves as Trustee. F3 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $91.01 to $93.50. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:07 UTC |
Havey AdamEVP, Business Operations
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 20,145 | $99.02 Strike: $49.64 | $1,994,757.90 |
DisclosureSEC source: 0001367644-21-000049 · wf-form4_161481282979100.xml · derivative · entry 6 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,145 shares Expires 2025-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey. F3 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.01 to $99.99. F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:07 UTC |
Havey AdamEVP, Business Operations
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 17,134 | $99.62 Strike: $30.63 | $1,706,889.08 |
DisclosureSEC source: 0001367644-21-000049 · wf-form4_161481282979100.xml · derivative · entry 5 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,134 shares Expires 2024-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey. F2 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.05 to $100.25. F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:07 UTC |
Havey AdamEVP, Business Operations
|
SaleCommon Stock | 20,145 | $99.02 | $1,994,757.90 |
DisclosureSEC source: 0001367644-21-000049 · wf-form4_161481282979100.xml · nonDerivative · entry 4 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,190 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey. F3 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.01 to $99.99. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:07 UTC |
Havey AdamEVP, Business Operations
|
Exercise / conversionCommon Stock | 20,145 | $49.64 | $999,997.80 |
DisclosureSEC source: 0001367644-21-000049 · wf-form4_161481282979100.xml · nonDerivative · entry 3 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:07 UTC |
Havey AdamEVP, Business Operations
|
SaleCommon Stock | 17,134 | $99.62 | $1,706,889.08 |
DisclosureSEC source: 0001367644-21-000049 · wf-form4_161481282979100.xml · nonDerivative · entry 2 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,190 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey. F2 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $98.05 to $100.25. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:07 UTC |
Havey AdamEVP, Business Operations
|
Exercise / conversionCommon Stock | 17,134 | $30.63 | $524,814.42 |
DisclosureSEC source: 0001367644-21-000049 · wf-form4_161481282979100.xml · nonDerivative · entry 1 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 17:14 UTC |
Strei KatherineEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 561 | $97.15 | $54,501.15 |
DisclosureSEC source: 0001367644-21-000042 · wf-form4_161437759770567.xml · nonDerivative · entry 5 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,500 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 17:14 UTC |
Strei KatherineEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 649 | $97.15 | $63,050.35 |
DisclosureSEC source: 0001367644-21-000042 · wf-form4_161437759770567.xml · nonDerivative · entry 4 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,061 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 22:12 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 819 | $97.15 | $79,565.85 |
DisclosureSEC source: 0001367644-21-000041 · wf-form4_161437750812785.xml · nonDerivative · entry 4 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,973 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 22:18 UTC |
Havey AdamEVP, Business Operations
|
Tax withholdingCommon Stock | 732 | $97.15 | $71,113.80 |
DisclosureSEC source: 0001367644-21-000047 · wf-form4_161437785866552.xml · nonDerivative · entry 5 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,190 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 22:18 UTC |
Havey AdamEVP, Business Operations
|
Tax withholdingCommon Stock | 739 | $97.15 | $71,793.85 |
DisclosureSEC source: 0001367644-21-000047 · wf-form4_161437785866552.xml · nonDerivative · entry 4 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,922 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 22:16 UTC |
Kirk SeanEVP, Manufacturing & Tech Ops
|
Tax withholdingCommon Stock | 285 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000045 · wf-form4_161437776370492.xml · nonDerivative · entry 5 Kirk Sean · CIK 0001778426 · EVP, Manufacturing & Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,935 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 22:16 UTC |
Kirk SeanEVP, Manufacturing & Tech Ops
|
Tax withholdingCommon Stock | 336 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000045 · wf-form4_161437776370492.xml · nonDerivative · entry 4 Kirk Sean · CIK 0001778426 · EVP, Manufacturing & Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,220 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 22:17 UTC |
Kramer RobertDirector · President and CEO
|
Tax withholdingCommon Stock | 860 | $97.15 | $83,549.00 |
DisclosureSEC source: 0001367644-21-000046 · wf-form4_161437780493924.xml · nonDerivative · entry 5 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,147 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 22:17 UTC |
Kramer RobertDirector · President and CEO
|
Tax withholdingCommon Stock | 1,716 | $97.15 | $166,709.40 |
DisclosureSEC source: 0001367644-21-000046 · wf-form4_161437780493924.xml · nonDerivative · entry 4 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,007 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 22:15 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
Tax withholdingCommon Stock | 799 | $97.15 | $77,622.85 |
DisclosureSEC source: 0001367644-21-000043 · wf-form4_161437768971580.xml · nonDerivative · entry 5 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,760 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 22:15 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
Tax withholdingCommon Stock | 764 | $97.15 | $74,222.60 |
DisclosureSEC source: 0001367644-21-000043 · wf-form4_161437768971580.xml · nonDerivative · entry 4 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,559 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 17:14 UTC |
Strei KatherineEVP, Chief HR Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 10,696 | $93.49 Strike: $93.49 | $999,969.04 |
DisclosureSEC source: 0001367644-21-000042 · wf-form4_161437759770567.xml · derivative · entry 6 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,696 Underlying: Common Stock · 10,696 shares Expires 2028-02-23 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 17:14 UTC |
Strei KatherineEVP, Chief HR Officer
|
Tax withholdingCommon Stock | 619 | $93.49 | $57,870.31 |
DisclosureSEC source: 0001367644-21-000042 · wf-form4_161437759770567.xml · nonDerivative · entry 3 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,710 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 17:14 UTC |
Strei KatherineEVP, Chief HR Officer
|
GrantCommon Stock | 2,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000042 · wf-form4_161437759770567.xml · nonDerivative · entry 2 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,329 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 17:14 UTC |
Strei KatherineEVP, Chief HR Officer
|
GrantCommon Stock | 2,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000042 · wf-form4_161437759770567.xml · nonDerivative · entry 1 Strei Katherine · CIK 0001709639 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,655 F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:12 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 16,043 | $93.49 Strike: $93.49 | $1,499,860.07 |
DisclosureSEC source: 0001367644-21-000041 · wf-form4_161437750812785.xml · derivative · entry 5 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,043 Underlying: Common Stock · 16,043 shares Expires 2028-02-23 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:12 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 1,010 | $93.49 | $94,424.90 |
DisclosureSEC source: 0001367644-21-000041 · wf-form4_161437750812785.xml · nonDerivative · entry 3 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,792 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:12 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
GrantCommon Stock | 4,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000041 · wf-form4_161437750812785.xml · nonDerivative · entry 2 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,802 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:12 UTC |
LINDAHL RICHARD SEVP, Chief Financial Officer
|
GrantCommon Stock | 4,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000041 · wf-form4_161437750812785.xml · nonDerivative · entry 1 LINDAHL RICHARD S · CIK 0001196632 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,790 F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:22 UTC |
El-Hibri FuadDirector · Chairman
|
GrantRestricted Stock Unit · Derivative | 13,906 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-008483 · doc4.xml · derivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,906 Underlying: Common Stock · 13,906 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On February 24, 2021, Mr. El-Hibri was granted 13,906 restricted stock units vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date. F3 · derivative.expiration_date: On February 24, 2021, Mr. El-Hibri was granted 13,906 restricted stock units vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:22 UTC |
El-Hibri FuadDirector · Chairman
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 27,808 | $0.00 Strike: $93.49 | $0.00 |
DisclosureSEC source: 0000899243-21-008483 · doc4.xml · derivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director · Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,808 Underlying: Common Stock · 27,808 shares Expires 2031-02-23 F2 · derivative.exercise_date: On February 24, 2021, Mr. El-Hibri was granted 27,808 stock options vesting in three approximately equal annual installments beginning on the day prior to the first anniversary of the grant date. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:18 UTC |
Havey AdamEVP, Business Operations
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 14,973 | $93.49 Strike: $93.49 | $1,399,825.77 |
DisclosureSEC source: 0001367644-21-000047 · wf-form4_161437785866552.xml · derivative · entry 6 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,973 Underlying: Common Stock · 14,973 shares Expires 2028-02-23 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:18 UTC |
Havey AdamEVP, Business Operations
|
Tax withholdingCommon Stock | 847 | $93.49 | $79,186.03 |
DisclosureSEC source: 0001367644-21-000047 · wf-form4_161437785866552.xml · nonDerivative · entry 3 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,661 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:18 UTC |
Havey AdamEVP, Business Operations
|
GrantCommon Stock | 3,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000047 · wf-form4_161437785866552.xml · nonDerivative · entry 2 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,508 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:18 UTC |
Havey AdamEVP, Business Operations
|
GrantCommon Stock | 3,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000047 · wf-form4_161437785866552.xml · nonDerivative · entry 1 Havey Adam · CIK 0001514588 · EVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,764 F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:16 UTC |
Kirk SeanEVP, Manufacturing & Tech Ops
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 12,835 | $93.49 Strike: $93.49 | $1,199,944.15 |
DisclosureSEC source: 0001367644-21-000045 · wf-form4_161437776370492.xml · derivative · entry 6 Kirk Sean · CIK 0001778426 · EVP, Manufacturing & Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,835 Underlying: Common Stock · 12,835 shares Expires 2028-02-23 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:16 UTC |
Kirk SeanEVP, Manufacturing & Tech Ops
|
Tax withholdingCommon Stock | 433 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000045 · wf-form4_161437776370492.xml · nonDerivative · entry 3 Kirk Sean · CIK 0001778426 · EVP, Manufacturing & Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,556 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:16 UTC |
Kirk SeanEVP, Manufacturing & Tech Ops
|
GrantCommon Stock | 3,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000045 · wf-form4_161437776370492.xml · nonDerivative · entry 2 Kirk Sean · CIK 0001778426 · EVP, Manufacturing & Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,989 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:16 UTC |
Kirk SeanEVP, Manufacturing & Tech Ops
|
GrantCommon Stock | 3,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000045 · wf-form4_161437776370492.xml · nonDerivative · entry 1 Kirk Sean · CIK 0001778426 · EVP, Manufacturing & Tech Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,780 F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:17 UTC |
Kramer RobertDirector · President and CEO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 59,898 | $93.49 Strike: $93.49 | $5,599,864.02 |
DisclosureSEC source: 0001367644-21-000046 · wf-form4_161437780493924.xml · derivative · entry 6 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,898 Underlying: Common Stock · 59,898 shares Expires 2028-02-23 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:17 UTC |
Kramer RobertDirector · President and CEO
|
Tax withholdingCommon Stock | 2,425 | $93.49 | $226,713.25 |
DisclosureSEC source: 0001367644-21-000046 · wf-form4_161437780493924.xml · nonDerivative · entry 3 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,723 F3 · security: Represents shares of common stock withheld to pay taxes. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:17 UTC |
Kramer RobertDirector · President and CEO
|
GrantCommon Stock | 14,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000046 · wf-form4_161437780493924.xml · nonDerivative · entry 2 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,148 F2 · shares: Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:17 UTC |
Kramer RobertDirector · President and CEO
|
GrantCommon Stock | 14,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001367644-21-000046 · wf-form4_161437780493924.xml · nonDerivative · entry 1 Kramer Robert · CIK 0001380956 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,173 F1 · shares: Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 22:15 UTC |
SARAN ATULEVP, Corp Dev, GC & Secretary
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 14,973 | $93.49 Strike: $93.49 | $1,399,825.77 |
DisclosureSEC source: 0001367644-21-000043 · wf-form4_161437768971580.xml · derivative · entry 6 SARAN ATUL · CIK 0001591070 · EVP, Corp Dev, GC & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,973 Underlying: Common Stock · 14,973 shares Expires 2028-02-23 F4 · derivative.exercise_date: Vests in three equal installments beginning on the day prior to the anniversary date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.